6N-cinnamoyl-β-naltrexamine and its p-nitro derivative. High efficacy κ-opioid agonists with weak antagonist actions

Ian Derrick, Humphrey A. Moynihan, Jillian Broadbear, James H. Woods, John W. Lewis

Resultado de la investigación: Articlerevisión exhaustiva

12 Citas (Scopus)

Resumen

6N-cinnamoyl-β-naltrexamine and its p-nitro derivative (7 and 8) are κ-opioid agonists of high potency and exceptional efficacy and are only weakly effective μ opioid antagonists. This contrasts with the p-methyl analogue which has only low efficacy κ-agonism but is a selective irreversible μ-antagonist like β-FNA.

Idioma originalEnglish (US)
Páginas (desde-hasta)167-172
Número de páginas6
PublicaciónBioorganic and Medicinal Chemistry Letters
Volumen6
N.º2
DOI
EstadoPublished - ene 23 1996
Publicado de forma externa

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine
  • Molecular Biology
  • Pharmaceutical Science
  • Drug Discovery
  • Clinical Biochemistry
  • Organic Chemistry

Huella

Profundice en los temas de investigación de '6N-cinnamoyl-β-naltrexamine and its p-nitro derivative. High efficacy κ-opioid agonists with weak antagonist actions'. En conjunto forman una huella única.

Citar esto